AnastoSEAL tackles gastrointestinal anastomotic leaks, affecting >10% of 14 million annual abdominal surgery patients globally. These leaks, manifesting days post-surgery, cause delayed recoveries, higher healthcare costs, and up to 33% mortality rate. Current solutions fail due to weak adhesion and lack of early detection. AnastoSEAL's unique solution offers high-performance adhesion and early leak detection using standard hospital imaging equipment like ultrasound and CT scans.
Dr Alexandre Anthis (co-inventor) leads an ETHZ team, combining 7+ years of materials research with top visceral surgeons. The market of leaks is estimated to 7 billion $, driven by delayed recovery and late detection. AnastoSEAL aims at fully eradicating this deadly complication from post-operative care.